Ruth M. Belin

1.0k total citations
15 papers, 744 citations indexed

About

Ruth M. Belin is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Ruth M. Belin has authored 15 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Genetics and 5 papers in Surgery. Recurrent topics in Ruth M. Belin's work include Inflammatory Bowel Disease (6 papers), Microscopic Colitis (5 papers) and Diabetes Management and Research (3 papers). Ruth M. Belin is often cited by papers focused on Inflammatory Bowel Disease (6 papers), Microscopic Colitis (5 papers) and Diabetes Management and Research (3 papers). Ruth M. Belin collaborates with scholars based in United States, Japan and Canada. Ruth M. Belin's co-authors include Yutaka Aoki, Robert P. Clickner, R Jeffries, Linda Phillips, Kathryn R. Mahaffey, Paul W. Ladenson, Neil R. Powe, Brad C. Astor, Zayna Nahas and Ralph P. Tufano and has published in prestigious journals such as Gastroenterology, The Journal of Clinical Endocrinology & Metabolism and The American Journal of Gastroenterology.

In The Last Decade

Ruth M. Belin

15 papers receiving 721 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruth M. Belin United States 9 426 211 151 151 87 15 744
Lucilla Gargano Italy 13 487 1.1× 163 0.8× 356 2.4× 153 1.0× 54 0.6× 15 869
Z Límanová Czechia 17 529 1.2× 132 0.6× 100 0.7× 84 0.6× 82 0.9× 60 804
M. D’Herbomez France 17 391 0.9× 132 0.6× 178 1.2× 114 0.8× 25 0.3× 47 699
WM Wiersinga Netherlands 9 843 2.0× 134 0.6× 177 1.2× 75 0.5× 100 1.1× 13 1.0k
Simona Fica Romania 16 230 0.5× 99 0.5× 120 0.8× 188 1.2× 36 0.4× 99 796
Nuri Kamel Türkiye 16 506 1.2× 133 0.6× 228 1.5× 70 0.5× 52 0.6× 28 750
Walter Reinhardt Germany 17 425 1.0× 107 0.5× 145 1.0× 53 0.4× 36 0.4× 43 847
M. Albareda Spain 12 704 1.7× 103 0.5× 363 2.4× 127 0.8× 35 0.4× 18 1.0k
Masako Matsumoto Japan 18 678 1.6× 82 0.4× 99 0.7× 95 0.6× 32 0.4× 66 953
Itxaso Rica Spain 16 353 0.8× 292 1.4× 273 1.8× 89 0.6× 38 0.4× 50 702

Countries citing papers authored by Ruth M. Belin

Since Specialization
Citations

This map shows the geographic impact of Ruth M. Belin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth M. Belin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth M. Belin more than expected).

Fields of papers citing papers by Ruth M. Belin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth M. Belin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth M. Belin. The network helps show where Ruth M. Belin may publish in the future.

Co-authorship network of co-authors of Ruth M. Belin

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth M. Belin. A scholar is included among the top collaborators of Ruth M. Belin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth M. Belin. Ruth M. Belin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Baker, Jennifer L., Carine de Beaufort, Ruth M. Belin, et al.. (2024). Considerations for the design and conduct of pediatric obesity pharmacotherapy clinical trials: Proceedings of expert roundtable meetings. Pediatric Obesity. 19(11). e13161–e13161. 2 indexed citations
2.
Dubinsky, Marla C., Remo Panaccione, James D. Lewis, et al.. (2022). Impact of Bowel Urgency on Quality of Life and Clinical Outcomes in Patients With Ulcerative Colitis. Crohn s & Colitis 360. 4(3). otac016–otac016. 26 indexed citations
3.
Sands, Bruce E., Laurent Peyrin‐Biroulet, Jarosław Kierkuś, et al.. (2021). Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn’s Disease. Gastroenterology. 162(2). 495–508. 109 indexed citations
4.
Sands, Bruce E., William J. Sandborn, Laurent Peyrin‐Biroulet, et al.. (2021). 132 EFFICACY AND SAFETY OF MIRIKIZUMAB AFTER 52-WEEKS MAINTENANCE TREATMENT IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE. Gastroenterology. 160(6). S–37. 9 indexed citations
5.
Gottlieb, Klaus, Jochen Schmitz, Richard E. Higgs, et al.. (2020). OP28 Gene expression (GE) values in a phase 2 trial of mirikizumab in ulcerative colitis (UC) correlate better with histopathology (HP) than endoscopy (EN) and Mayo scores. Journal of Crohn s and Colitis. 14(Supplement_1). S025–S026. 2 indexed citations
6.
Dubinsky, Marla C., Remo Panaccione, James D. Lewis, et al.. (2020). S0683 Absence of Bowel Urgency Is Associated With Improvements in Clinical Outcomes in Patients With Ulcerative Colitis Receiving Mirikizumab. The American Journal of Gastroenterology. 115(1). S341–S341. 3 indexed citations
7.
Sands, Bruce E., William J. Sandborn, Laurent Peyrin‐Biroulet, et al.. (2019). 1003 – Efficacy and Safety of Mirikizumab (LY3074828) in a Phase 2 Study of Patients with Crohn's Disease. Gastroenterology. 156(6). S–216. 19 indexed citations
8.
Bokvist, Krister, Ying Ding, William Landschulz, et al.. (2019). Gastrin analogue administration adds no significant glycaemic benefit to a glucagon‐like peptide‐1 receptor agonist acutely or after washout of both analogues. Diabetes Obesity and Metabolism. 21(7). 1606–1614. 1 indexed citations
9.
Rosenstock, Julio, Freddy G. Eliaschewitz, Cory R. Heilmann, et al.. (2009). Comparison of Prandial AIR Inhaled Insulin Alone to Intensified Insulin Glargine Alone and to AIR Insulin Plus Intensified Insulin Glargine in Patients with Type 2 Diabetes Previously Treated with Once-Daily Insulin Glargine. Diabetes Technology & Therapeutics. 11(s2). S–63. 10 indexed citations
10.
11.
12.
Nahas, Zayna, Tarik Y. Farrag, Frank R. Lin, Ruth M. Belin, & Ralph P. Tufano. (2006). A Safe and Cost‐Effective Short Hospital Stay Protocol to Identify Patients at Low Risk for the Development of Significant Hypocalcemia After Total Thyroidectomy. The Laryngoscope. 116(6). 906–910. 59 indexed citations
13.
14.
Belin, Ruth M., Paul W. Ladenson, Karen A. Robinson, & Neil R. Powe. (2002). Development and use of evidence-based clinical practice guidelines for thyroid disease. Endocrinology and Metabolism Clinics of North America. 31(3). 795–817. 4 indexed citations
15.
Belin, Ruth M., et al.. (1974). Experience with a cholinesterase histochemical technique for rectal suction biopsies in the diagnosis of Hirschsprung's disease. Journal of Clinical Pathology. 27(3). 207–213. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucilla Gargano Breakdown of academic impact, for papers by Z Límanová Breakdown of academic impact, for papers by M. D’Herbomez Breakdown of academic impact, for papers by WM Wiersinga Breakdown of academic impact, for papers by Simona Fica Breakdown of academic impact, for papers by Nuri Kamel Breakdown of academic impact, for papers by Walter Reinhardt Breakdown of academic impact, for papers by M. Albareda Breakdown of academic impact, for papers by Masako Matsumoto Breakdown of academic impact, for papers by Itxaso Rica
Rankless by CCL
2026